CAMP4 Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. CAMP4 Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0% to $294,949,000. Profit margin reached -11%. Total operating expenses were $129,110,000.
Profit Margin
| 2014 | 235.90M | 11.80M | 5% |
|---|---|---|---|
| 2015 | 250.60M | 16.50M | 6.59% |
| 2016 | 280.71M | 16.94M | 6.03% |
| 2017 | 351.10M | -7.15M | -2.04% |
| 2018 | 365.91M | 16.61M | 4.54% |
| 2019 | 363.8M | 18.39M | 5.06% |
| 2020 | 366.10M | -78.77M | -21.52% |
| 2021 | 308.58M | -21.15M | -6.86% |
| 2022 | 295.83M | -31.14M | -10.53% |
| 2023 | 294.94M | -32.49M | -11.02% |
CAMP Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 294.94M | 295.83M | 308.58M | 366.10M | 363.8M | 365.91M | 351.10M | 280.71M | 250.60M | 235.90M |
Cost of revenue | 185.93M | 173.95M | 186.18M | 222.80M | 216.03M | 215.02M | 207.75M | 177.76M | 163.20M | 155.97M |
Gross profit | 109.01M | 121.88M | 122.40M | 143.30M | 147.76M | 150.89M | 143.35M | 102.95M | 87.40M | 79.93M |
Operating exp. | ||||||||||
Research and development | 24.57M | 28.44M | 25.81M | 29.43M | 27.65M | 25.76M | 22.00M | 19.80M | 19.85M | 21.05M |
Selling and marketing | 47.38M | 48.56M | 46.20M | 60.53M | 49.89M | 50.09M | 49.04M | 23.38M | 20.44M | 19.83M |
Total operating expenses | 129.11M | 134.75M | 125.87M | 159.96M | 120.05M | 142.93M | 142.01M | 74.87M | 62.46M | 61.58M |
Operating income | -21.48M | -15.31M | -3.86M | -16.77M | 19.69M | 7.95M | 1.34M | 28.08M | 24.94M | 18.34M |
Other income (expenses), net | -9.85M | -14.74M | -16.72M | -41.55M | 12.87M | 31.03M | 1.59M | 1.85M | -140K | -67K |
Income before tax | -31.33M | -30.06M | -20.59M | -58.32M | 23.85M | 28.70M | -6.96M | 22.34M | 24.8M | 17.91M |
Income tax expense | 1.15M | 1.08M | 561K | 20.45M | -1.33M | 10.68M | -1.09M | 4.57M | 8.29M | 6.10M |
Net income | -32.49M | -31.14M | -21.15M | -78.77M | 18.39M | 16.61M | -7.15M | 16.94M | 16.50M | 11.80M |
Earnings per share | ||||||||||
Basic EPS | -0.9 | -0.88 | -0.62 | -2.34 | 0.53 | 0.47 | -0.2 | 0.46 | 0.46 | 0.34 |
Diluted EPS | -0.9 | -0.88 | -0.62 | -2.34 | 0.52 | 0.46 | -0.2 | 0.46 | 0.45 | 0.33 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |